Biobytes

We Decode Data forHealthy Aging

We uncover fundamental answers to disease hidden in data,so everyone can enjoy a healthier old age.

Our Perspective

Conventional methods could not unravel the complexity of life.

Biobank is the world's first multicenter biobank dedicated to patients with sarcopenia. Built with partner institutions including Wonju Severance Christian Hospital, M-Bank is collecting and accumulating blood, tissue, and clinical-history data from 3,000 patients with sarcopenia and controls by 2027. These data support more accurate sarcopenia diagnosis and biomarker discovery for drug development, serving as core infrastructure for global technology transfer and AI-powered precision medicine.

Biobytes takes a different approach.

Biobank is the world's first multicenter biobank dedicated to patients with sarcopenia. Built with partner institutions including Wonju Severance Christian Hospital, M-Bank is collecting and accumulating blood, tissue, and clinical-history data from 3,000 patients with sarcopenia and controls by 2027. These data support more accurate sarcopenia diagnosis and biomarker discovery for drug development, serving as core infrastructure for global technology transfer and AI-powered precision medicine.

Mission

Unite biomedical big data and AI to solve intractable diseases and make healthy aging a reality.

Our mission is clear: extract biological meaning from the vast stores of hospital data, then turn those insights into practical solutions and medicines that extend patients' healthspan.

Vision

Become a Tech-Bio leader developing innovative medicines from world-class data specialized in sarcopenia and metabolic disease.

We go beyond analytics services and health supplements. Starting with our proprietary biobank ecosystem, we are building a technology platform that continuously creates first-in-class drug pipelines recognized by the global pharmaceutical market.

Core Values

Three forces that drive Biobytes forward

Data-Driven

Decisions grounded in data

We rely on exceptional real-world data in both scale and quality—including more than 15 years of prospective cohort follow-up—never on experience or guesswork alone.

Convergence

Disciplines in perfect convergence

Experts in clinical medicine, bioinformatics, and deep-learning AI remove disciplinary boundaries and work together toward one goal.

Real-World Impact

Value that reaches patients

We refuse to let technology remain in the lab. We translate it into diagnostics, health products, and new medicines that meaningfully improve patients' quality of life.

People are what ultimately make this ambitious vision possible.

From clinicians on the front line of care to AI architects from global technology companies,meet the exceptional experts who make up the Biobytes team.

Meet our leadership and researchers